Jefferies Group’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Other funds holding RARE
Jefferies Group's RARE Position: Q2 2021 in Review
Jefferies Group sold out of Ultragenyx Pharmaceutical (RARE) in Q2 2021, closing a stake of 12,133 shares — an estimated $1.38M sold.
Jefferies Group first reported a position in RARE in Q3 2015 and held it in 5 quarters. The position peaked at $1.38M in Q1 2021. 241 funds tracked by Wall St. Rank hold RARE as of Q2 2021.
- Jefferies Group reported no remaining Ultragenyx Pharmaceutical position as of Q2 2021 after selling out during the quarter.
- Jefferies Group sold 12,133 Ultragenyx Pharmaceutical shares in Q2 2021, an estimated $1.38M.
- Jefferies Group first reported a position in Ultragenyx Pharmaceutical in Q3 2015 and held it in 5 quarters.
- Jefferies Group's Ultragenyx Pharmaceutical position peaked at $1.38M in Q1 2021.
- 241 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2021.
Based on Jefferies Group's 13F filing for Q2 2021, filed 16 Aug 2021.